Principal Financial Group’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,953
| Closed | -$190K | – | 2428 |
|
|
2024
Q1 | $190K | Sell |
12,953
-1,182
| -8% | -$17.4K | ﹤0.01% | 2184 |
|
|
2023
Q4 | $146K | Sell |
14,135
-1,396
| -9% | -$14.4K | ﹤0.01% | 2212 |
|
|
2023
Q3 | $122K | Buy |
15,531
+2,002
| +15% | +$15.7K | ﹤0.01% | 2250 |
|
|
2023
Q2 | $135K | Buy |
13,529
+725
| +6% | +$7.24K | ﹤0.01% | 2243 |
|
|
2023
Q1 | $114K | Buy |
12,804
+1,793
| +16% | +$15.9K | ﹤0.01% | 2287 |
|
|
2022
Q4 | $121K | Buy |
+11,011
| New | +$121K | ﹤0.01% | 2271 |
|